文献速递胸部CT

I期肺腺癌术前CT与病理肿瘤直径的差异及其与术后复发的关系

Discrepancy Between Preoperative CT and Pathological Tumor Diameters in Stage I Lung Adenocarcinoma and Its Association with Postoperative Recurrence.
PubMed 文献 · Acad Radiol · 2026-03-26

回顾性分析239例2019-2021年接受根治性切除的I期肺腺癌患者,CT直径用AI辅助3D分割并由胸部放射科医师审核,病理直径取甲醛固定标本最大肿瘤切面测量。CT与病理直径中度至高度相关(r=0.876,P<.001),平均正偏倚2.9 mm;影像高估(CT-病理差异>3 mm)是术后复发的独立预测因素,整合模型 optimism-corrected C-index 为0.818。

要点

  • CT测量倾向于高估I期肺腺癌肿瘤大小,平均正偏倚为2.9 mm。
  • CT-病理直径差异>3 mm(影像高估)是术后复发的独立预测因素。
  • 将CT-病理直径差异纳入预后模型(optimism-corrected C-index 0.818)可能改善术后风险分层。

核心结论

  • CT测量倾向于高估肿瘤大小,过度高估(差异>3 mm)与更高的术后复发风险独立相关;将CT-病理直径差异纳入预后模型可能改善术后风险分层。

研究设计与样本

  • 回顾性分析2019-2021年接受根治性切除的I期肺腺癌患者239例,CT直径采用AI辅助3D分割并由经验丰富的胸部放射科医师审核,病理大小在甲醛固定标本最大肿瘤切面测量;采用Pearson r评估相关性、Bland-Altman分析评估一致性,按CT-病理差异(<-3 mm、-3至3 mm、>3 mm)分组,用Kaplan-Meier比较无复发生存期(RFS),多变量Cox比例风险回归识别独立预测因素,整合预后模型进行内部验证。

诊断标准与关键数值

  • CT与病理肿瘤直径中度至高度相关(r=0.876,P<.001),Bland-Altman分析显示平均正偏倚2.9 mm;按CT-病理差异分组(<-3 mm、-3至3 mm、>3 mm)RFS差异有统计学意义(P<.001);多变量Cox分析中影像高估(CT-病理差异>3 mm)、更高的病理T分期、年龄较大和男性为复发的独立预测因素;整合模型 optimism-corrected C-index 为0.818,校正良好,可实现风险分层。

临床应用与阅片要点

  • 阅片时需注意CT测量对I期肺腺癌肿瘤直径存在平均2.9 mm的正偏倚,CT-病理差异>3 mm的影像高估与术后复发风险独立相关;作者认为将CT-病理直径差异纳入预后模型可能改善术后风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To assess the concordance between preoperative CT-measured and postoperative pathological tumor diameters in stage I lung adenocarcinoma, and to examine whether their discrepancy is associated with postoperative recurrence.

MATERIALS AND METHODS: We retrospectively analyzed patients with stage I lung adenocarcinoma who underwent curative resection from 2019-2021. CT tumor diameter was obtained using AI-assisted 3D segmentation and reviewed by experienced thoracic radiologists. Pathological size was measured on the maximal tumor section of formalin-fixed specimens. Correlation was assessed using Pearson's r, and agreement examined with Bland-Altman analysis. Patients were grouped by CT-pathology discrepancy (<-3 mm, -3 to 3 mm, >3 mm). Recurrence-free survival (RFS) was compared using Kaplan-Meier analysis, and independent predictors of recurrence were identified via multivariable Cox proportional hazards regression. An integrated prognostic model incorporating significant variables was internally validated.

RESULTS: A total of 239 patients were included in the study and of those, 48 recurred. CT and pathological tumor diameters were moderately to highly correlated (r = 0.876, P < .001), with a mean positive bias of 2.9 mm. RFS differed significantly across groups (P < .001). Multivariable Cox analysis identified imaging overestimation (CT-pathology discrepancy >3 mm), higher pathological T stage, older age and male as independent predictors of recurrence. The integrated model showed acceptable discrimination (optimism-corrected C-index 0.818) and calibration, enabling risk stratification.

CONCLUSION: CT measurements tend to overestimate tumor size, and excessive overestimation (difference >3 mm) was independently associated with higher postoperative recurrence risk. Incorporating CT-pathology discrepancies into prognostic models may improve postoperative risk stratification.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Lu M, Ding M, Dai Q, et al. Discrepancy Between Preoperative CT and Pathological Tumor Diameters in Stage I Lung Adenocarcinoma and Its Association with Postoperative Recurrence. Acad Radiol. 2026. PMID: 41896056. doi:10.1016/j.acra.2026.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。